Low gene expression conferred by association of an allele of the 5-HT2C receptor gene with antipsychotic-induced weight gain

Am J Psychiatry. 2005 Mar;162(3):613-5. doi: 10.1176/appi.ajp.162.3.613.

Abstract

Objective: Association has been reported between the C allele of a -759C/T polymorphism in the promoter of the 5-HT2C receptor gene (HTR2C) and antipsychotic-induced weight gain, suggesting that polymorphic HTR2C expression influences this phenotype. The authors tested this polymorphism, and other promoter variants, for effects on HTR2C transcription.

Method: Six HTR2C promoter haplotypes constructed from four polymorphisms were cloned into a luciferase reporter gene plasmid. Their transcriptional activities were then compared in two human cell lines.

Results: All haplotypes containing the -759C allele showed less transcriptional activity than haplotypes containing the -759T allele. The A allele of a -997G/A polymorphism was also associated with reduced expression.

Conclusions: These findings suggest that the -759C allele is functional and results in relative underexpression of HTR2C. Reduced expression of HTR2C mRNA may underlie vulnerability to weight gain following antipsychotic treatment.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alleles
  • Antipsychotic Agents / adverse effects*
  • Antipsychotic Agents / therapeutic use
  • Body Mass Index
  • Cell Line
  • Clozapine / adverse effects*
  • Clozapine / therapeutic use
  • Gene Expression / genetics
  • Genetic Markers
  • Haplotypes / genetics
  • Humans
  • Obesity / chemically induced*
  • Obesity / genetics
  • Phenotype
  • Polymorphism, Genetic
  • Polymorphism, Single Nucleotide / genetics
  • Receptor, Serotonin, 5-HT2C / genetics*
  • Schizophrenia / drug therapy*
  • Transcription, Genetic / genetics
  • Transfection / methods
  • Weight Gain / drug effects
  • Weight Gain / genetics

Substances

  • Antipsychotic Agents
  • Genetic Markers
  • Receptor, Serotonin, 5-HT2C
  • Clozapine